article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Pharma 64
article thumbnail

Interchangeability of biosimilars in the EU – the industry impact

European Pharmaceutical Review

She has experience on issues arising during the lifecycle of medicinal products, including optimisation of IP regulatory rights, advertising, product liability, competition and market access issues. Chris was named a ‘Rising Star’ in the 2022 Legal 500 Rankings for Life Sciences and Healthcare. Directive 2001/83 (as amended).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pathbreakers: The journey of first generics

Pharmaceutical Technology

“According to the FDA, the introduction of generic medicines offers patients “same as brand” drugs at 39% lower-than-average price,” says Surbhi Gupta, an industry analyst within Frost & Sullivan’s healthcare and life sciences practice area. from 2001 to 2022.”

article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2001. Founded 2010. million in funding.

Sales 76
article thumbnail

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 1

Evolve Your Success

In the last several years of my career, I have all been in healthcare, predominantly in the medical device and a couple of software businesses. My why for my career is inspiring people’s growth so that together we can transform healthcare. For context, Cyber Tuesday, which is the Tuesday after Thanksgiving was developed in 2001.

Sales 52
article thumbnail

Reality Bites: Disappointment in the R&D Sector

Pharmaceutical Technology

” When you consider only five big companies managed to earn 10% of their revenues from products launched after 2001 and those products still only generated income of $30.4bn, you are left with an industry where 90% of its revenue comes from medicines which are more than five years old. .”